v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
| Column | Value |
|---|---|
| Trial registration number | NCT04873349 |
|
Full text link
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
|
|
First author
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
|
|
Contact
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Not reported |
|
Registration date
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
2021-05-05 |
|
Recruitment status
Last imported at : Feb. 13, 2023, 8:44 a.m. Source : ClinicalTrials.gov |
Completed |
|
Study design
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
RCT |
|
Allocation
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Randomized |
|
Design
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Parallel |
|
Masking
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Blind label |
|
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
|
Study aim
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Treatment |
|
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: adults. confirmed sars-cov-2 diagnosis (positive polymerase chain reaction by nasopharyngeal swab). mild to moderate covid-19 patients. no history of the current use of olive leaf capsules supplement. |
|
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
severe and critical covid-19 patients who need hospitalization. patients need ventilatory support or showing chronic obstructive pulmonary disease (copd). patients showing any chronic disease (except hypertension and diabetes mellitus). patients who have multiorgan failure. 3. use of alcohol, other investigational medicines, and illegal drugs (during the last 30 days). |
|
Number of arms
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
2 |
|
Funding
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Shimaa M. Abdelgawad |
|
Inclusion age min
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
18 |
|
Inclusion age max
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
100 |
|
Countries
Last imported at : Feb. 13, 2023, 8:44 a.m. Source : ClinicalTrials.gov |
Egypt |
|
Type of patients
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
Mild disease at enrollment |
|
Severity scale
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
1: Mild disease at enrollment |
|
Total sample size
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
60 |
|
primary outcome
Last imported at : Feb. 13, 2023, 8:44 a.m. Source : ClinicalTrials.gov |
Improvement of analysis (CBC);Improvement of analysis (CRP);Improvement of analysis (D-dimer);Improvement of analysis (ESR);Improvement of analysis (Ferritin);Improvement of analysis (LDH);Improving the clinical symptoms in mild to moderate COVID -19 patients;Viral clearance in mild to moderate COVID -19 patients |
|
Notes
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
None |
|
Phase
Last imported at : Feb. 13, 2023, 8:44 a.m. Source : ClinicalTrials.gov |
Not reported |
|
Arms
Last imported at : May 7, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 921, "treatment_name": "Olive leaves capsule", "treatment_type": "Nutrition", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}] |